Oikonomou EK, Suchard MA, McGuire DK, Khera R, et al. Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes. Diabetes Care 2022 Feb 4. pii: 144528. doi: 10.2337/dc21-1765.
PMID: 35120199